Reply to Lupo et al-Reference-Cited by-同舟云学术

Reply to Lupo et al

Published:2018-09-11 Issue:5 Volume:68 Page:892-893
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Navarro José-Tomás¹²,Muncunill Josep¹²,Garcia Olga¹²,Hernández-Rodríguez Águeda³,Baptista Maria Joao¹²

Affiliation:

1. Department of Hematology, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona

2. Josep Carreras Leukaemia Research Institute, IJC Can Ruti Campus

3. Department of Microbiology, Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/5/892/27783882/ciy788.pdf

Reference10 articles.

1. Utility of Epstein-Barr virus biomarkers in human immunodeficiency virus–related lymphomas in the modern combined antiretroviral therapy era;Lupo;Clin Infect Dis,2019

2. Plasma EBV-load as an early biomarker and prognostic factor of HIV-related lymphomas [manuscript published online ahead of print 29 June 2018];Muncunill;Clin Infect Dis,2018

3. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma;Leruez-Ville;HIV Med,2012

4. Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma;Ul-Haq;Med Oncol,2018

5. High risk features contrast with favorable outcomes in HIV-associated Hodgkin lymphoma in the modern cART era, ANRS CO16 LYMPHOVIR cohort;Besson;Clin Infect Dis,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era;AIDS;2019-05-01